Nectar Lifesciences Limited (NSE:NECLIFE)
India · Delayed Price · Currency is INR 10.59
-0.36 (-3.29%)
Oct 7, 2026, 3:29 PM IST
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 2.06 billion as of October 7, 2026. That makes Nectar Lifesciences the world's 36,739th most valuable company and 2,686th in India. Its market cap has decreased by 36.52% in one year.
Market Cap
2.06B
Enterprise Value
806.17M
Revenue
145.00K
Global Rank
Country Rank
#2,686 India
PE Ratio
n/a
ChartMarket Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has decreased from 2.87B to 2.06B, a decrease of -28.21%. That is a compound annual growth rate of -1.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 2.06B | -52.74% |
| Dec 31, 2025 | 4.35B | -50.21% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 10.83B |
| Bafna Pharmaceuticals | 8.96B |
| Amanta Healthcare | 7.39B |
| Valiant Laboratories | 6.79B |
| Brooks Laboratories | 1.60B |
| Par Drugs and Chemicals | 1.53B |
| Alpa Laboratories | 1.25B |
| Balaxi Pharmaceuticals | 1.23B |